Crossmark

Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features

Crossref DOI link: https://doi.org/10.1007/s00259-018-4250-6

Published Online: 2019-01-13

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Giannini, V. https://orcid.org/0000-0001-5052-8231
Mazzetti, S.

Bertotto, I.

Chiarenza, C.

Cauda, S.

Delmastro, E.

Bracco, C.

Di Dia, A.

Leone, F.

Medico, E.

Pisacane, A.

Ribero, D.

Stasi, M.

Regge, D.
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology - Ref.9970)

Fondazione piemontese per la ricerca sul cancro, FPRC (5 per mille 2015 Ministero della Salute.)
License Information

Text and Data Mining valid from 2019-01-13
More Information

Article History

Received: 1 October 2018

Accepted: 26 December 2018

First Online: 13 January 2019

Compliance with ethical standards

:

: All authors declare that they have no conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.